Skip to content

Clinical basic research on the effect of jianpi yiqi decoction on CD4+T cell subgroup of HIV/AIDS

Study the Mechanism of Jianpi yiqi Decotion on Delaying HIV/AIDS Disease Process Based on Regulation of Differentiation, Response and Apoptosis of CD4+T Cells

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018304
Enrollment
Unknown
Registered
2018-09-10
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

Group 1:Jianpi yiqi Decotion
Group 2:Jianpi Yiqi Decoction simulate agent

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria for HIV infection; (2) CD4+T lymphocyte level: 250 ~ 400 /ul; (3) aged from 18 to 60 years male and female; (4) conform to TCM syndrome differentiation standards; (5) subjects voluntarily participated and informed consent.

Exclusion criteria

Exclusion criteria: (1) acute infection period; (2) receiving antiviral drugs (taking standard antiviral treatment regimen, good tolerance, no treatment failure or termination of antiviral treatment) or traditional Chinese medicine (taking traditional Chinese medicine for treating AIDS or decoction for 3 months or more); (3) those whose antivirus treatment has not been stopped for more than 3 months; (4) patients with severe heart and liver (ALT and AST were more than twice the normal value) and renal diseases (BUN and CR were abnormal); (5) severe opportunistic infections or tumors; (6) severe mental and neurological diseases; (7) persons with allergies; (8) history of alcoholism (daily drinking more than 250 ml), or with alcohol dependence syndrome (refers to the repeated a large number of drinking caused by special mental state, characterized by thirst for alcohol and often need to compulsive drinking experience, can be continuous or discontinuous, stage of symptoms, often a person stops drinking is drinking cause dependence on alcohol spirit and body); (9) women preparing for pregnancy, pregnancy and lactation; (10) patients participating in other treatment studies and researchers believe that other reasons are not suitable for clinical trial participants.

Design outcomes

Primary

MeasureTime frame
CD4+ T-lymphocyte subsets count;

Secondary

MeasureTime frame
CD8+ T-lymphocyte subsets count;HIV viral load;Symptoms and signs of traditional Chinese Medicine;Opportunistic infection;CD4+CD45RA+ T lymphocytes;CD4+CD45RO+ T lymphocytes;WHOQOL-HIV- BREF;Report of outcome indicators in patients with measuring scale (PRO);

Countries

China

Contacts

Public ContactXU Liran

The First Affiliated Hospital of Henan University of Chinese Medicine

xuliran666@sina.com+86 13633818030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026